Document is current
Any future updates will be listed below
-
Authors
Liebenow, Brittany
Jiang, Angela
DiMarco, Emily K.
Sands, L. Paul
Moya-Mendez, Mary
Laxton, Adrian W.
Siddiqui, Mustafa S.
ul Haq, Ihtsham
Kishida, Kenneth T.
-
Funding
Funding for this research was provided by:
National Institutes of Health, United States (R01DA048096, F31DA053174, F30DA053176, R01DA048096, R01MH121099, R01MH121099)
- License Information
-
More Information
Article History
Received: 8 August 2022
Accepted: 27 January 2024
First Online: 4 March 2024
Competing interests
: Dr. Ihtsham ul Haq has received salary support for research from Allergan, Boston Scientific, Great Lakes Neurotechnology, and Pfizer. He has consulted for compensation for Boston Scientific and Medtronics. Dr. Mustafa Siddiqui has received research support as a site Principal Investigator for clinical trials from Neuraly, University of Rochester, Michael J. Fox-Neuropoint Alliance, Theravance Biopharma, Impax Laboratories, Sun Pharma, Abbvie, Boston Scientific Neuromodulation, Biogen and Sunovion. He has received honoraria as a scientific advisor from Abbvie and Boston Scientific Neuromodulation. Dr. Adrian Laxton is a consultant and member of the safety committee for Monteris Medical. All other authors have nothing to disclose.
